These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18301126)

  • 21. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Olajide D
    J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term use and abuse of benzodiazepines.
    Carranza J
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):254-8. PubMed ID: 6108579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin treatment of anxiety in patients with substance use disorders.
    Raza S; Siddiqui UA; Megna JL; Schwartz TL; Batki SL
    Ann Pharmacother; 2010 May; 44(5):937-8. PubMed ID: 20388860
    [No Abstract]   [Full Text] [Related]  

  • 28. Pregabalin in the treatment of alcohol and benzodiazepines dependence.
    Oulis P; Konstantakopoulos G
    CNS Neurosci Ther; 2010; 16(1):45-50. PubMed ID: 20070788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The withdrawal syndrome in benzodiazepine dependence and its management].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation with pregabalin in schizophrenia.
    Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
    J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
    Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
    Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin for the treatment of generalised anxiety disorder.
    Montgomery SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2139-54. PubMed ID: 17020438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist substitution--a treatment alternative for high-dose benzodiazepine-dependent patients?
    Liebrenz M; Boesch L; Stohler R; Caflisch C
    Addiction; 2010 Nov; 105(11):1870-4. PubMed ID: 20456294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term anxiolytic therapy: the issue of drug withdrawal.
    Lader M
    J Clin Psychiatry; 1987 Dec; 48 Suppl():12-6. PubMed ID: 2891684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment methods for discontinuation of long-term benzodiazepine use].
    Oude Voshaar RC; Gorgels WJ; Mol AJ; Couvée JE; van Balkom AJ; Zitman FG
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1347-50. PubMed ID: 11484431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study.
    Ciesielski AS; Samson S; Steinhoff BJ
    Epilepsy Behav; 2006 Nov; 9(3):424-31. PubMed ID: 16949344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benzodiazepine withdrawal syndrome].
    Perugi G; Michelini S; Petracca A; Cassano GB
    Clin Ter; 1991 Apr; 137(2):117-24. PubMed ID: 1675166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin in benzodiazepine withdrawal.
    Biermann T; Bleich S; Kornhuber J; Hillemacher T
    Pharmacopsychiatry; 2007 Nov; 40(6):292-3. PubMed ID: 18030656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.